MZI poised to deliver record March quarter production ahead of robust maiden fiscal 2018 profit.
MZI Resources (ASX: MZI) provided a positive operational update on Friday morning, noting that in the first two months of the March quarter the group had already achieved its second highest level of quarterly sales since operations commenced.
This follows on from strong Heavy Mineral Concentrate (HMC) production in the December quarter from its Keysbrook operation located in Western Australia.
In the current quarter MZI has completed two major shipments of leucoxene products totalling 6500 tonnes of L70 and 7500 tonnes of its high-value L88. The group has also shipped 3118 tonnes of zircon concentrate, with a further 2000 tonnes anticipated by the end of the quarter which would result in record total quarterly sales volumes.
With MZI’s continued optimisation progress having achieved increased throughput rates for HMC and L88 Picton Mineral Separation Plant, MZI’s next bulk leucoxene shipments are anticipated early in the June quarter.
Improvements continue at the Picton plant with work expected to be completed during March and April. Work is well advanced at the eastern mining area to install and tie in the new transportable integrated Mining Feed Unit (MFU) which has previously been used successfully in mineral sands mining. Commissioning is planned for late March.
Production to increase as plant upgrades are commissioned in March
The forecast increased production due to the new MFU positions MZI to benefit from continued strengthening global market conditions for mineral sands products, particularly in titanium minerals.
Today’s news is consistent with broker expectations which point to a strong transition to profitability in fiscal 2018. Bell Potter is forecasting the group to generate a net profit of $14 million, representing earnings per share of 7 cents.
This implies a heavily discounted PE multiple of 3.7 relative to Thursday’s closing price of 26 cents. It would appear that MZI is currently being valued as an unprofitable explorer rather than a company delivering strong production, and on the verge of delivering a robust maiden profit.
Bell Potter has a buy recommendation on the stock with a 12 month price target of 50 cents, implying upside of nearly 100% to the company’s current trading range.
It should be noted here that broker projections and price targets are only estimates and may not be met. Also, historical data in terms of earnings performance and/or share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.